A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Conditions
Graves' Disease · Graves Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Diabetes Associates Medical Group, Orange, California, United States
Havana Research Institute LLC., Pasadena, California, United States
Contact: Study coordinator (John De Beixedon, MD) · drjohn@havanaresearchinstitute.com · 626-698-9794Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location, Fleming Island, Florida, United States
The Center for Diabetes and Endocrine Care, Fort Lauderdale, Florida, United States
Ilumina Medical Research LLC, Kissimmee, Florida, United States
Johnson County Clin-Trials, Inc., Lenexa, Kansas, United States
Metro Detroit Endocrinology Center, Dearborn, Michigan, United States
Profound Research, Farmington Hills, Michigan, United States
Endocrine Associates of West Village PC, New York, New York, United States
Research Institute of Dallas, Dallas, Texas, United States
Juno Research, Houston, Texas, United States
Tekton Research Irving, Irving, Texas, United States
Biopharma Informatic, LLC, McAllen, Texas, United States
Tekton Research - McKinney, McKinney, Texas, United States
Contact: Study coordinator (Muhammad Siddiqui, MD) · muhammad.siddiqui@tektonresearch.com · 972-777-6011Southern Endocrinology Associates PA, Mesquite, Texas, United States
Consano Clinical Research, Shavano Park, Texas, United States
New Hospitals, Tbilisi, Georgia
LLC Todua Clinic, Tbilisi, Georgia